Anti-GAD antibodies were first linked to SPS and later associated with the aforementioned spectrum of anti-GAD neurologic diseases: autoimmune epilepsy, limbic encephalitis, cerebellar ataxia, and nystagmus [15]. Here, GAD1 is linked to Nystagmus.